Sildenafil citrate
- CAS No.
- 171599-83-0
- Chemical Name:
- Sildenafil citrate
- Synonyms
- sildinafil;Xidinafei;5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[5,4-e]pyrimidin-7-one citrate salt;Viagra;denafiL;Sildenafi;uk92480-10;silaenafil;citrate saL;Revatio citrate
- CBNumber:
- CB9407725
- Molecular Formula:
- C28H38N6O11S
- Molecular Weight:
- 666.7
- MOL File:
- 171599-83-0.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/9/25 14:54:50
Melting point | 187-189°C |
---|---|
storage temp. | 2-8°C |
solubility | DMSO: >20mg/mL |
form | white powder |
color | White |
Water Solubility | 3.488g/L(temperature not stated) |
Merck | 14,8489 |
BCS Class | 1 |
Stability | Store in Freezer |
InChIKey | DEIYFTQMQPDXOT-UHFFFAOYSA-N |
SMILES | C1(=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1)C1=NC(C2N(N=C(CCC)C=2N1)C)=O.C(O)(C(=O)O)(CC(=O)O)CC(=O)O |
CAS DataBase Reference | 171599-83-0(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H315-H319-H335 | |||||||||
Precautionary statements | P305+P351+P338 | |||||||||
Hazard Codes | Xi | |||||||||
Risk Statements | 36/37/38 | |||||||||
Safety Statements | 36 | |||||||||
WGK Germany | 3 | |||||||||
RTECS | TL4284390 | |||||||||
HS Code | 2933595960 | |||||||||
NFPA 704 |
|
Sildenafil citrate price More Price(6)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML3033 | Sildenafil citrate ≥98% (HPLC) | 171599-83-0 | 10MG | ₹9093 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML3033 | Sildenafil citrate ≥98% (HPLC) | 171599-83-0 | 50MG | ₹36707.58 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | PHR1807 | Sildenafil Citrate Pharmaceutical Secondary Standard; Certified Reference Material | 171599-83-0 | 500MG | ₹16053.48 | 2022-06-14 | Buy |
TCI Chemicals (India) | S0986 | Sildenafil Citrate | 171599-83-0 | 25MG | ₹3000 | 2022-05-26 | Buy |
TCI Chemicals (India) | S0986 | Sildenafil Citrate | 171599-83-0 | 100MG | ₹5700 | 2022-05-26 | Buy |
Sildenafil citrate Chemical Properties,Uses,Production
Description
Sildenafil is a potent inhibitor of phosphodiesterase 5 (PDE5) with IC50 values of 3.6 and 3 nM for PDE5 activity in isolated rabbit platelets and human corpus cavernosum, respectively. It is selective for PDE5 over PDE1 and PDE3 (IC50s = 0.26 and 65 μM, respectively). Sildenafil reverses glucose-induced decreases in angiopoietin 1 (ANG1) expression and reduction of capillary-like tube formation by mouse dermal endothelial cells in vitro and increases the number of functional blood vessels and regional blood flow in the sciatic nerve in a db/db mouse model of diabetic peripheral neuropathy. It increases the ratio of maximum intracavernosal pressure to mean arterial blood pressure (ICP/MAP), a measure of erectile function, in castrated rats when administered at a dose of 20 mg/kg per day. Sildenafil (0.5 mg/kg) also reduces cardiac arrest and resuscitation-induced increases in angiotensin II , angiotensin converting enzyme (ACE), ACE2, and various angiotensin receptors and increases survival in a porcine model of ischemia/reperfusion injury. Formulations containing sildenafil have been used in the treatment of erectile dysfunction, pulmonary arterial hypertension, and high-altitude pulmonary edema associated with altitude sickness.
Chemical Properties
Sildenafil citrate is a white to off-white crystalline powder soluble in DMF, acetic acid and slightly soluble in methanol. Solubility of sildenafil citrate is pH dependent and it decreases with increase of pH. pH ranges between 3.7 and 3.8 and the pKa from 8.2 to 9.6.
Uses
Sildenafil citrate is an orally active selective type 5 cgmp phosphodiesterase inhibitor that is used in the treatment of erectile dysfunction and primary pulmonary hypertension.
Definition
ChEBI: Sildenafil citrate is the citrate salt of sildenafil. It has a role as a vasodilator agent and an EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor. It contains a sildenafil.
General Description
Sildenafil Citrate is the citrate salt form of sildenafil, an orally bioavailable pyrazolopyrimidinone derivative structurally related to zaprinast, with vasodilating and potential anti-inflammatory activities. Upon oral administration, sildenafil selectively targets and inhibits cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), thereby inhibiting the PDE5-mediated degradation of cGMP found in smooth muscle and increasing cGMP availability. This results in prolonged smooth muscle relaxation in the corpus cavernosum of the penis, thereby causing vasodilation, blood engorgement and a prolonged penile erection. In the smooth muscle of the pulmonary vasculature, the increase in cGMP results in smooth muscle relaxation, vasodilation of the pulmonary vascular bed, relieving pulmonary hypertension and increasing blood flow in the lungs. In addition, sildenafil may reduce airway inflammation and mucus production.
Biological Activity
Orally active, potent inhibitor of phosphodiesterase 5 (PDE5) (IC 50 = 4 nM). Enhances nitric oxide-dependent relaxation of human corpus cavernosum in vitro .
Pharmacokinetics
Analysis of Middle Eastern data (mean ± SD) revealed Cmax = 398.9 ± 107.7 ng/ml; Tmax = 1.84 ± 0.22 h; t1/2 = 2.66 ± 0.97 h; AUC0–24 = 1475 ± 515.3 ng.h/ml; AUC0-∞ = 1556 ± 567.58 ng.h/ml.
Side effects
The more common side effects of sildenafil citrate include: headache, skin flushing, indigestion, abnormal vision, nasal congestion, back pain, nausea, dizziness, rash, etc.
Safety Profile
A poison by ingestion. Human systemic effects. When heated to decomposition it emits toxic vapors of NOx and SOx.
Synthesis
The synthesis of sildenafil citrate was first reported in the Bioorganic & Medicinal Chemistry Letters, Vol 6, pp. 1819, 1824, 1996. The reaction scheme is reproduced below. Sildenafil was reported in this journal as "a potent and selective inhibitor of type 5 PDE with utility for the treatment of male erectile dysfunction".
The first step of the synthesis is the reaction of a diketoester (1) and hydrazine to give the pyrazole ring. The regioselective N-methylation of the pyrazole and hydrolysis gives a carboxylic acid (3). Compound (3) is then reacted with HNO3 and H2SO4 to give a nitrated product.
This is then followed by a carboxamide formation and the reduction of the nitro group. The compound (4) is then acylated under basic conditions and this produces the pyrazolopyrimidinone (6). (6) is then chlorosulphonylated selectively on the 5'-position of the phenyl ring. This can then couple with an amine to give sildenafil (7).
www.ch.ic.ac.uk/local/projects/p_hazel/synthesis2.html
Sildenafil citrate Preparation Products And Raw materials
Raw materials
1of3
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Cadila Pharmaceuticals Ltd | +91-7069076657 +91-7069076657 | Ahmedabad, India | 54 | 58 | Inquiry |
ANWITA APIS | +919000311012 | Hyderabad, India | 198 | 58 | Inquiry |
THE MOLECULEZ | +91-7506703683 +91-7506703683 | Maharashtra, India | 79 | 58 | Inquiry |
AARTIA KEM SCIENCE | +91-8291072530 +91-8291072530 | Maharashtra, India | 70 | 58 | Inquiry |
Apotex Pharmachem India Pvt Ltd | +91-8022891034 +91-8022891000 | Karnataka, India | 109 | 58 | Inquiry |
Macleods Pharmaceuticals Limited | +91-2266762800 +91-2266762800 | Maharashtra, India | 116 | 58 | Inquiry |
Hetero Drugs Limited | +91-4023704923 +91-4023704923 | Telangana, India | 296 | 58 | Inquiry |
Virchow Groups | +919394860022 | Telangana, India | 24 | 58 | Inquiry |
Smilax Laboratories Limited | +91-8919514965 +91-8008333438 | Telangana, India | 28 | 58 | Inquiry |
HRV Global Life Sciences | +91-9820219686 +91-9820219686 | Telangana, India | 379 | 58 | Inquiry |
Supplier | Advantage |
---|---|
Cadila Pharmaceuticals Ltd | 58 |
ANWITA APIS | 58 |
THE MOLECULEZ | 58 |
AARTIA KEM SCIENCE | 58 |
Apotex Pharmachem India Pvt Ltd | 58 |
Macleods Pharmaceuticals Limited | 58 |
Hetero Drugs Limited | 58 |
Virchow Groups | 58 |
Smilax Laboratories Limited | 58 |
HRV Global Life Sciences | 58 |
Related articles
- Sildenafil Citrate: A Revolutionary Approach in the Pharmaceutical World
- Sildenafil citrate, is a compound that has revolutionized the treatment of erectile dysfunction (ED) and other medical conditi....
- May 22,2024
- Sildenafil citrate: Chemical synthesis and pharmaceutical characteristics
- Sildenafil citrate, a PDE5 inhibitor with high selectivity, has been used by millions of men for the treatment of erectile dys....
- Apr 12,2023
171599-83-0(Sildenafil citrate)Related Search:
1of4
chevron_right